The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject

NCT05737576 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: HR011408 injection; NovoRapid®
DRUG: NovoRapid®；HR011408 injection
DRUG: HR011408 injection; NovoRapid®
DRUG: NovoRapid®；HR011408 injection
DRUG: HR011408 injection; NovoRapid®
DRUG: HR011408 injection; NovoRapid®

Sponsor

Jiangsu HengRui Medicine Co., Ltd.